NCT05806996View on ClinicalTrials.gov

A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Bladder Spasms

Interventions

DRUG

Magnesium

Intravenous infusion, load 50 mg/Kg with infusion of 15 mg/Kg/hour

DRUG

Placebo

Equivalent volume of normal saline

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Minnesota, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT05806996 - A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures | Biotech Hunter | Biotech Hunter